Pregnancy: Carbetocin is contraindicated during pregnancy and must not be used for the induction of labour (see Contraindications).
Breastfeeding: No significant effects on milk let-down have been reported during clinical trials. Small amounts of carbetocin have been shown to pass from plasma into breast milk of nursing women (see Pharmacology: Pharmacokinetics under Actions). The small amounts transferred into colostrum or breast milk after a single injection of carbetocin, and subsequently ingested by the infant are assumed to be degraded by enzymes in the gut.
Breast-feeding does not need to be restricted after the use of carbetocin.